NOVEMBER 202119Carbon Medical TechnologiesBiocompatible Innovations for Urology Implantsurology space with various medical devices and products. The company is an FDA-registered medical device manufacturer with ISO 13485 certified CGMP compliant quality systems. It operates an ISO Class 7 Cleanroom environment and provides contract manufacturing. "With over 27 years of institutional knowledge, our company has had an impeccable track record with the FDA and EU notified bodies with over 20 products developed and approved or cleared for sale on the market", states Tina Wittchow, the COO at CMT, adding "the R&D focus, manufacturing capabilities, regulatory and quality expertise is core to our company." The company focuses on offering robust solutions to address SUI and encouraging competitive partnerships in the marketplace for a flawless combination treatment plan for addressing the patient's needs.Taking CMT to the next phase of its expansive growth, its team continues developing new products, expanding sales of its current product portfolio, and raising awareness among the physician and patient community. The company's newest product BiomarC Restore is a lumpectomy fiducial marker designed to provide patients with comfort and physicians with confidence by positioning and maintaining the marker in the surgical cavity created during a lumpectomy procedure recently received FDA clearance. "We are excited about BiomarC Restore and are looking forward to a market launch in 2022", adds Stephanie. CMT is looking to grow its contract manufacturing services and expand the presence of its products worldwide by exploring new partnerships overseas with a focus on Asian markets, including Japan. With over 20 years of R&D expertise, we have created tools and training, including the proprietary `Bent Needle' periurethral injection approach, which simplifies injection and contributes to positive patient outcomes
< Page 9 | Page 11 >